| Time (UTC+8) | Topic | Speaker | Moderator | Abstract | Slides | Video | |
|---|---|---|---|---|---|---|---|
| 08:05 - 08:15 | Registration | ||||||
| 08:15 - 08:30 | Opening Remark |
Shou-Tung Chen
Pi-Sheng Wang
|
Shou-Tung Chen
Pi-Sheng Wang
|
||||
| 08:30 - 09:00 | What can we contribute to breast cancer in Taiwan ? |
Mien-Chie Hung
|
King-Jen Chang
Hong-Tai Chang
|
Video | |||
| 09:00 - 09:30 | Genetic testing for hereditary breast cancer - what we’ve learned today and what to do tomorrow in Taiwan? |
Wen-Ling Kuo
|
Yuan-Ching Chang
Chia-Herng Yue
|
Video | |||
| 09:30 - 10:00 | To whom should adjuvant PARP inhibitors be offered? |
Charles E. Geyer
|
Chiun-Sheng Huang
Hung-Wen Lai
|
||||
| 10:00 - 10:30 | Coffee Break | ||||||
| 10:30 - 11:00 | The changing treatment landscape for HR+HER2-mBC patient with CDK4/6i |
Dejan Juric
|
Ling-Ming Tseng
Yi-Fang Tsai
|
Video | |||
| 11:00 - 11:30 | Treatment options with CDK4&6inhibitor, S-1, and PARP-inhibitor for HR-positive HER2-negative early breast cancer: Japan experience |
Hiroko Masuda
|
King-Jen Chang
Guo-Shiou Liao
|
Video | |||
| 11:30 - 11:50 | Mucinous carcinoma of the breast |
Yoon-Sim Yap
|
Wen-Hung Kuo
Chih-Chiang Hung
|
||||
| 11:50 - 12:20 | Metaplatic carcinoma of breast: biology, challenges, and strategic direction |
Ching-Hung Lin
|
Chen-Hsiang Chang
Yao-Jen Chang
|
Video | |||
| 12:20 - 13:00 | [Luncheon Symposium] Thinking outside of the box? What are the possible options for metastatic breast cancer |
Wei-Wu Chen
|
Tsu-Yi Chao
Kuo-Ting Lee
|
Video | |||
| 13:00 - 13:30 | Break | ||||||
| 13:30 - 14:00 | Maximizing clinical benefit of atezolizumab in triple negative breast cancer |
Chun-Yu Liu
|
Ming-Shen Dai
Dah-Cherng Yeh
|
Video | |||
| 14:00 - 14:30 | The Benefit of Extended Adjuvant Therapy in HER2+ eBC Patients with High Recurrence Risk |
Diana Lüftner
|
Fang-Ming Chen
Ta-Chung Chao
|
||||
| 14:30 - 15:00 | New horizon of TNBC: clinical outcomes and perspective of A Novel Trop-2 Antibody-Drug conjugate |
Hope S. Rugo
|
Yen-Shen Lu
Chiao Lo
|
||||
| 15:00 - 15:30 | Coffee Break | ||||||
| 15:30 - 16:00 | Raising the bar for patients with HR+/HER2- Early Breast Cancer |
Nadia Harbeck
|
Chiun-Sheng Huang
Ming-Yang Wang
|
||||
| 16:00 - 16:30 | Unsolved questions in CDK4/6i mBC setting |
Fatima Cardoso
|
Shin-Cheh Chen
Chieh-Han Chuang
|
Video | |||
| 16:30 - 17:00 | HER2 dual blockade treatment benefit on eBC patient survival and Singapore experience with FlexCare |
Soo Chin Lee
|
Shyr-Ming Sheen-Chen
Shih-Che Shen
|
Video | |||
| 17:00 - 17:30 | Past, present and future of HER2+ breast cancer treatment |
Paul Cornes
|
Liang-Chih Liu
Chung-Chin Yao
|
Video |
| Time (UTC+8) | Topic | Speaker | Moderator | Abstract | Slides | Video | |
|---|---|---|---|---|---|---|---|
| 08:10 - 08:20 | Registration | ||||||
| 08:20 - 08:50 | Local-regional management after neoadjuvant therapy - surgeon’s view |
Laura Dominici
|
Jyh-Cherng Yu
Huan-Ming Hsu
|
Video | |||
| 08:50 - 09:20 | Recent progress of antibody-drug conjugate in breast cancer treatment |
Shanu Modi
|
Kun-Ming Rau
Chia-Ming Hsieh
|
Video | |||
| 09:20 - 09:50 | Identify unmet needs for improving care for patients with chemotherapy-induced neutropenia |
Chi-Cheng Huang
|
Shou-Tung Chen
Yuan-Chiang Chung
|
Video | |||
| 09:50 - 10:20 | Recent advances in HER2 directed therapy in HER2 positive advanced breast cancer |
Soo Chin Lee
|
Ming-Feng Hou
Ming-Hsin Yeh
|
Video | |||
| 10:20 - 11:00 | Coffee Break | ||||||
| 11:00 - 11:30 | Experience sharing: how do we initiate and conduct large scale IIT |
Jee Hyun Kim
|
Chun-Yu Liu
Hsien-Kun Chang
|
Video | |||
| 11:30 - 12:00 | Local therapy for the primary site in De Novo Stage IV breast cancer |
Seema A. Khan
|
Dar-Ren Chen
Shih-Hsin Tu
|
||||
| 12:00 - 12:30 | New Strategic Approach of Neoadjuvant in Early Breast Cancer |
Chin-Sheng Hung
|
Yao-Lung Kuo
Shen-Liang Shih
|
Video | |||
| 12:30 - 13:10 | [Luncheon Symposium] Recent Roles of Vacuum assisted breast biopsy in Korea |
Sang-Won Kim
|
Fiona Tsui-Fen Cheng
Frank Fu Ou-Yang
|
||||
| 13:10 - 13:20 | Break | ||||||
| 13:20 - 13:50 | Bone-targeted agents for the management of breast cancer patients with bone metastases |
Dwan-Ying Chang
|
Hsien-Tang Yeh
Tsen-Long Yang
|
Video | |||
| 13:50 - 14:10 | Pseudocirrhosis: a unique presentation of liver metastasis in advanced breast cancer |
Wei-Li Ma
|
Cheng-Ping Yu
Zhi-Jie Hong
|
Video | |||
| 14:10 - 14:20 | Coffee Break | ||||||
| 14:20 - 14:50 | Neoadjuvant chemotherapy backbone, which is the optimal option? |
Sibylle Loibl
|
Chi-Cheng Huang
Ming-Feng Hou
|
||||
| 14:50 - 15:20 | The considerations about adjuvant treatment choices after neoadjuvant therapy |
Giampaolo Bianchini
|
Shin-Cheh Chen
Chien-Liang Liu
|
Video | |||
| 15:20 - 15:50 | Avoiding breast and axillary surgery after neoadjuvant therapy |
Joerg Heil
|
Chao-Ming Hung
Chin-Yao Lin
|
||||
| 15:50 - 16:20 | Adjuvant radiotherapy after neoadjuvant treatment |
Boon H. Chua
|
Sung-Hsin Kuo
Chin-Hua Tsai
|
Video | |||
| 16:20 - 16:40 | Panel Discussion |
Sibylle Loibl
Giampaolo Bianchini
Joerg Heil
Boon H. Chua
Wei-Pang Chung
Jiun-I Lai
Yen-Dun Tzeng
|
Ling-Ming Tseng
Ming-Shen Dai
|
Video | |||
| 16:40 - 17:05 | Award Ceremony & Closing |
Shou-Tung Chen
|
Shou-Tung Chen
|